BLOG
Blog
Drug Development Timelines: How Health Canada’s 30-Day Regulatory Review Process Could Provide an Advantage
The EMA recently updated their clinical trial application process. Discover how Health Canada's CTA process compares.
Blog
Four Key Steps to Optimizing a Large Molecule Bioanalytical Program
Learn how Altasciences advances your biologic drug development with robust bioanalytical support. Expertise in large molecule bioanalysis fosters program success.
Blog
Five Reasons to Choose Canada for Your Clinical Trials—From the Webinar Demystifying the Conduct of Clinical Trials in Canada
Five advantages of conducting clinical trials in Canada. Read this overview to find out more.
